SCHEMBL6605631

SCHEMBL6605631

COc1ccc(C2=NN(C(=O)c3ccccc3NC(=O)c3ccco3)CCC2)cc1OC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 3/20 0.52
CYP1A2 P05177 3/20 0.52
CYP3A4 P08684 2/20 0.52
CYP2C9 P11712 2/20 0.52
CYP2C19 P33261 2/20 0.52
MAPK1 P28482 3/20 0.49
POLB P06746 2/20 0.49
TSHR P16473 5/20 0.49
KDM4E B2RXH2 3/20 0.49
HSD17B10 Q99714 3/20 0.49
CRHBP P24387 1/20 0.49
CRHR2 Q13324 1/20 0.49
RAB9A P51151 2/20 0.48
ALOX15 P16050 1/20 0.48
KMT2A Q03164 4/20 0.47
MEN1 O00255 3/20 0.47
HPGD P15428 2/20 0.47
ESR1 P03372 1/20 0.47
MAPT P10636 1/20 0.47
ALDH1A1 P00352 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6602424 0.87 KMT2A (0.46) MAPK1POLBTSHRHSD17B10KMT2A
SCHEMBL6602739 0.86 MAOB (0.53) POLBKMT2AMAPTALDH1A1SMN1; SMN2
SCHEMBL6602045 0.86 MAOB (0.55) POLBKDM4ERAB9AKMT2AMEN1
SCHEMBL6600737 0.85 NPSR1 (0.54) NPSR1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL6601212 0.85 MAOB (0.48) NPSR1CYP1A2CYP2C19POLBTSHR
SCHEMBL6600413 0.84 TLR7 (0.50) POLBKDM4ERAB9AKMT2AMAPT
SCHEMBL6601582 0.84 MAOB (0.48) CYP1A2CYP2C19MAPK1POLBTSHR
SCHEMBL6601154 0.84 SMN1; SMN2 (0.50) NPSR1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL6604600 0.83 ABCG2 (0.52) POLBTSHRKDM4ERAB9AKMT2A
SCHEMBL143512 0.82 AAK1 (0.52) MAPK1POLBTSHRKDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0922036-B1 ARYLALKANOYL PYRIDAZINES MERCK PATENT GMBH (DE) 2004-03-24 EP disclosed
US-6479494-B1 THEY INHIBIT SELECTIVELY PHOSPHODIESTERASE IV, WHICH CAUSES AN INCREASE OF THE INTRACELLULAR CAMP LEVEL AS CAMP INHIBITS BONE DECREASING CELLS AND STIMULATES BONE INCREASING CELLS FOR TREATMENT OF OSTEOPOROSIS MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2002-11-12 US disclosed
US-6107295-A Arylalkanoyl pyridazines MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2000-08-22 US disclosed